Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$877M |
| 2 |
Booking.com
BKNG
|
+$370M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$329M |
| 4 |
Boeing
BA
|
+$303M |
| 5 |
Walmart Inc
WMT
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$544M |
| 2 |
iShares MBS ETF
MBB
|
+$461M |
| 3 |
NVIDIA
NVDA
|
+$452M |
| 4 |
T-Mobile US
TMUS
|
+$426M |
| 5 |
Apple
AAPL
|
+$408M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.15% |
| 2 | Healthcare | 3.06% |
| 3 | Financials | 2.35% |
| 4 | Consumer Discretionary | 2.28% |
| 5 | Industrials | 1.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7626
CALL
Webster Financial
WBS
$12.6B
| $1.24M | ﹤0.01% |
23,300
+7,200
| +45% | +$399K |
|
7627
PUT
PDS Biotechnology
PDSB
$11.5M
| $1.24M | ﹤0.01% |
+99,000
| New | +$773K |
|
|
ETRN
7628
PUT
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $1.24M | ﹤0.01% |
145,900
-3,000
| -2% | -$25.4K |
|
7629
PUT
Global X Autonomous & Electric Vehicles ETF
DRIV
$375M
| $1.24M | ﹤0.01% |
43,800
+21,100
| +93% | +$578K |
|
7630
PUT
H.B. Fuller
FUL
$3.31B
| $1.24M | ﹤0.01% |
19,500
+1,700
| +10% | +$114K |
|
7631
CALL
Talos Energy
TALO
$2.84B
| $1.24M | ﹤0.01% |
79,300
-55,200
| -41% | -$763K |
|
7632
German American Bancorp
GABC
$1.9B
| $1.24M | ﹤0.01% |
33,225
+17,930
| +117% | +$751K |
|
|
EBIX
7633
DELISTED
Ebix Inc
EBIX
| $1.24M | ﹤0.01% |
36,483
-13,357
| -27% | -$414K |
|
7634
Atea Pharmaceuticals
AVIR
$436M
| $1.24M | ﹤0.01% |
57,481
+53,467
| +1,332% | +$1.61M |
|
7635
PUT
NovaGold Resources
NG
$3.67B
| $1.23M | ﹤0.01% |
154,100
-23,400
| -13% | -$220K |
|
|
TVTY
7636
PUT
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.23M | ﹤0.01% |
46,900
+11,500
| +32% | +$289K |
|
7637
Energy Recovery
ERII
$400M
| $1.23M | ﹤0.01% |
54,113
-194,220
| -78% | -$3.83M |
|
|
KRA
7638
CALL
DELISTED
Kraton Corporation
KRA
| $1.23M | ﹤0.01% |
38,200
+16,600
| +77% | +$586K |
|
7639
ALX Oncology
ALXO
$285M
| $1.23M | ﹤0.01% |
22,536
-36,677
| -62% | -$2.19M |
|
7640
PUT
Axogen
AXGN
$2.69B
| $1.23M | ﹤0.01% |
57,000
+1,800
| +3% | +$36.4K |
|
7641
iShares S&P India Nifty 50 Index Fund
INDY
$558M
| $1.23M | ﹤0.01% |
+26,350
| New | +$1.19M |
|
|
CHS
7642
CALL
DELISTED
Chicos FAS, Inc.
CHS
| $1.23M | ﹤0.01% |
187,300
+65,700
| +54% | +$283K |
|
7643
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.61B
| $1.23M | ﹤0.01% |
12,292
-73,093
| -86% | -$7.32M |
|
7644
Grid Dynamics Holdings
GDYN
$656M
| $1.23M | ﹤0.01% |
81,907
+42,482
| +108% | +$666K |
|
7645
CALL
Vanguard FTSE Developed Markets ETF
VEA
$237B
| $1.23M | ﹤0.01% |
23,900
+3,900
| +20% | +$201K |
|
7646
CALL
Veeco
VECO
$2.93B
| $1.23M | ﹤0.01% |
51,200
+23,200
| +83% | +$531K |
|
7647
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$295M
| $1.23M | ﹤0.01% |
+17,997
| New | +$1.21M |
|
7648
PUT
ProShares Short S&P500
SH
$856M
| $1.23M | ﹤0.01% |
19,975
-3,600
| -15% | -$229K |
|
7649
PUT
iShare MSCI Eurozone ETF
EZU
$9.92B
| $1.23M | ﹤0.01% |
+24,900
| New | +$1.23M |
|
7650
CALL
Neogen
NEOG
$2.63B
| $1.23M | ﹤0.01% |
26,700
-6,100
| -19% | -$282K |
|
Similar funds
Citadel Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Citadel Advisors held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Citadel Advisors's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.
By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
- Citadel Advisors added most to AT&T in Q2 2021, an estimated $877M increase.
- Citadel Advisors's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
- Citadel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
- Citadel Advisors's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
- Citadel Advisors opened 1,965 new positions and closed 1,500 in Q2 2021.
- Citadel Advisors's portfolio value rose 9.6% quarter-over-quarter to $447B.
Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.